Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immunic Inc. June 29, 202698.5%
-
Alnylam Pharmaceuticals Inc. May 18, 202389.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +11,250 | $70.20 | $789,750 |
| Aug 18, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −11,250 | $450.00 | $5,062,500 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +11,250 | $131.21 | $1,476,113 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −549 | $267.14 | $146,660 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −729 | $268.56 | $195,780 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −245 | $269.79 | $66,099 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −431 | $271.68 | $117,094 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −660 | $273.16 | $180,286 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −882 | $273.75 | $241,448 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −301 | $275.63 | $82,965 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,263 | $277.16 | $350,053 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,239 | $278.01 | $344,454 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −432 | $280.03 | $120,973 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −372 | $281.10 | $104,569 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −802 | $282.03 | $226,188 |
Questions about Michael W. Bonney
What boards is Michael W. Bonney on?
Michael W. Bonney sits on the boards of Alnylam Pharmaceuticals Inc., Autolus Therapeutics plc American Depositary Share and Immunic Inc.
How long has Michael W. Bonney served on boards?
Our records show at least 5 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.